Effects of Exercise Prior to Radical Prostatectomy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-80
SponsorYale University

About this trial

This pilot study will explore the metabolic and psychological effects of High-Intensity Interval Training (HIIT) exercise as well as its impact on patient recovery from radical prostatectomy.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Scheduled or intended treatment with radical prostatectomy at Yale New Haven Hospital

English language fluency

Clinically localized low, intermediate or high risk by National Comprehensive Cancer Network (NCCN) criteria

Able to attend 2 in person exercise training sessions per week for four-six weeks

Disqualifiers

Treatment with non-surgical modality

Prior therapy for prostate cancer (e.g. radiation therapy or focal therapy)

Already engaged in regular exercise (>60 minutes per week)

Unstable cardiovascular disease

Trial design

Design model

Single group

Treatments tested in this trial

  • High-intensity interval training (HIIT) exercise

    Behavioral

    The intervention will consist of vigorous physical activity for a goal of 60 minutes each week for a minimum of four weeks prior to prostatectomy.

Treatment groups

20 Participants
are divided into 1 treatment group
Group A: Radical prostatectomy + High-Intensity Interval Training (HIIT)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Mean concentration N-lactoyl phenylalanine

Mean concentration N-lactoyl phenylalanine (pg/ml) in blood

Time frame
Pre-exercise (Baseline) and post-excercise (4 weeks)

Secondary outcomes

1

Mean score Memorial Anxiety Scale for Prostate Cancer (MAXPC)

Questionnaire specifically designed to identify and measure cancer-related anxiety in men diagnosed with prostate cancer. Total score range is 0 to 54, with a higher score indicating a greater level of anxiety.

Time frame
Pre-exercise (Baseline) and post-exercise (4 weeks)
2

Mean score Expanded Prostate Cancer Index Composite Short Form (EPIC-26)

A comprehensive instrument designed to evaluate patient function and bother after prostate cancer on five health-related quality of life domains each scored on a scale of 0 to 100. Higher scores indicate better function and fewer symptoms or lower treatment bother.

Time frame
Pre-exercise (Baseline) and post-exercise (4 weeks)
3

Percentage of participants that used opioids

Percentage of participants that used opioids post prostatectomy

Time frame
Post operative (Day 1)
4

Percentage of participants readmitted

Percentage of participants readmitted to hospital post prostatectomy.

Time frame
Post operative (Day 1) up to 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: